e-learning
resources
Munich 2014
Saturday, 06.09.2014
PG02 Current clinical problems in pulmonology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
HR-CT of fibrosing lung disease: problems and variants
D. Hansell (London, United Kingdom)
Source:
International Congress 2014 – PG02 Current clinical problems in pulmonology
Session:
PG02 Current clinical problems in pulmonology
Session type:
Postgraduate Course
Number:
55
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Hansell (London, United Kingdom). HR-CT of fibrosing lung disease: problems and variants. International Congress 2014 – PG02 Current clinical problems in pulmonology
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Neurofibromatosis-associated lung disease: a case series and literature review
Source: Eur Respir J 2007; 29: 210-214
Year: 2007
HRCT in the diagnosis of diffuse lung disease - overlap issues
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010
Prevalence of progressive fibrosing interstitial lung disease
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Amyloid-and nonamyloid-deposition disease in the lung: novel manifestations
Source: Annual Congress 2013 –Ceremony for ERS Award for Rare Pulmonary Disease (financially supported by GlaxoSmithKline) followed by Symposium: Autoimmunity and lung diseases in humans
Year: 2013
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019
Year: 2019
The natural history of progressive fibrosing interstitial lung diseases
Source: Eur Respir J, 55 (6) 2000085; 10.1183/13993003.00085-2020
Year: 2020
Genetics of fibrosing lung diseases
Source: Eur Respir J 2005; 25: 915-927
Year: 2005
Genetic susceptibilty and manifestation of progressive fibrosing interstitial lung diseases.
Source: Virtual Congress 2020 – New clinical insights into idiopathic pulmonary fibrosis
Year: 2020
HRCT of drug-induced lung diseases
Source: International Congress 2017 – PG8 High-resolution computed tomography for pulmonologists: basics and beyond
Year: 2017
Genetics variants in familial interstitial pneumonia and progressive fibrosing interstitial lung disease (PF-ILD)
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021
Aspergillus
-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease?
Source: Eur Respir Rev, 30 (162) 210103; 10.1183/16000617.0103-2021
Year: 2021
Identification of the pathological pattern by transbronchial lung cryobiopsies in patients with fibrosing diffuse parenchymal lung disease
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
HRCT of cystic lung diseases
Source: International Congress 2017 – PG8 High-resolution computed tomography for pulmonologists: basics and beyond
Year: 2017
Nintedanib in patients with chronic fibrosing interstitial lung diseases with progressive phenotype: the INBUILD trial
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension
Year: 2019
Antifibrotics effects of nintedanib on lung fibroblasts derived from patients with progressive fibrosing intertitial lung diseases
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
Lung cancer in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 17: 1216-1219
Year: 2001
Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease.
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021
Quantitative analysis of pulmonary cysts and emphysema on computed tomography: Lymphangioleiomyomatosis, Birt-Hogg-Dubé syndrome and chronic obstructive lung disease
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Interstital lung diseases: update 2005
Source: Annual Congress 2005 - Clinical year in review
Year: 2005
Clusters, classification and epidemiology of interstitial lung diseases: concepts, methods and critical reflections
Source: Eur Respir J 2001; 18: 101S-106S
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept